AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 30th, there was short interest totaling 7,802,276 shares, a drop of 17.4% from the January 15th total of 9,443,727 shares. Based on an average trading volume of 845,645 shares, the days-to-cover ratio is presently 9.2 days. Currently, 5.9% of the company’s shares are short sold. Currently, 5.9% of the company’s shares are short sold. Based on an average trading volume of 845,645 shares, the days-to-cover ratio is presently 9.2 days.
Analyst Ratings Changes
Several research analysts recently commented on AHCO shares. Canaccord Genuity Group raised their price target on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Weiss Ratings raised shares of AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 30th. Zacks Research upgraded shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Finally, Wall Street Zen cut shares of AdaptHealth from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $14.25.
Get Our Latest Stock Report on AHCO
AdaptHealth Trading Up 1.1%
Insider Transactions at AdaptHealth
In other news, Director David Solomon Williams III sold 5,000 shares of the firm’s stock in a transaction dated Thursday, December 4th. The stock was sold at an average price of $9.43, for a total value of $47,150.00. Following the transaction, the director directly owned 45,045 shares in the company, valued at $424,774.35. This trade represents a 9.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.55% of the company’s stock.
Institutional Trading of AdaptHealth
A number of hedge funds and other institutional investors have recently modified their holdings of the business. PNC Financial Services Group Inc. lifted its stake in shares of AdaptHealth by 22.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after acquiring an additional 1,279 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in AdaptHealth by 6.6% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 27,095 shares of the company’s stock worth $256,000 after purchasing an additional 1,671 shares during the last quarter. MetLife Investment Management LLC raised its position in shares of AdaptHealth by 3.1% in the 4th quarter. MetLife Investment Management LLC now owns 57,364 shares of the company’s stock valued at $571,000 after purchasing an additional 1,749 shares in the last quarter. CWM LLC boosted its stake in shares of AdaptHealth by 17.5% during the 3rd quarter. CWM LLC now owns 12,306 shares of the company’s stock valued at $110,000 after buying an additional 1,835 shares during the last quarter. Finally, Arizona State Retirement System boosted its stake in shares of AdaptHealth by 9.3% during the 3rd quarter. Arizona State Retirement System now owns 27,937 shares of the company’s stock valued at $250,000 after buying an additional 2,367 shares during the last quarter. 82.67% of the stock is owned by hedge funds and other institutional investors.
AdaptHealth Company Profile
AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.
The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.
See Also
- Five stocks we like better than AdaptHealth
- Think You Missed Silver? You’re Wrong. Here’s Why.
- This $15 Stock Could Go Down as the #1 Stock of 2026
- America’s 1776 happening again
- [No Brainer Gold Play]: “Show me a better investment.”
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
